Argenica Therapeutics Limited (ASX:AGN)
Australia · Delayed Price · Currency is AUD 0.1050
-0.0050 (-4.55%)
Jun 22, 2026, 10:05 AM AEST
Argenica Therapeutics Market Cap
Argenica Therapeutics has a market cap or net worth of 14.13 million as of June 18, 2026. Its market cap has decreased by -86.55% in one year.
Market Cap
14.13M
Enterprise Value
9.09M
Revenue
1.01M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.11
Market Cap Chart
Since June 11, 2021, Argenica Therapeutics's market cap has decreased from 19.02M to 14.13M, a decrease of -25.73%. That is a compound annual growth rate of -5.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 19, 2026 | 14.13M | -62.71% |
| Dec 31, 2025 | 37.89M | -53.04% |
| Dec 31, 2024 | 80.70M | 59.59% |
| Dec 29, 2023 | 50.57M | 29.28% |
| Dec 30, 2022 | 39.12M | -35.98% |
| Dec 31, 2021 | 61.10M | 221.15% |
| Jun 11, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EZZ Life Science Holdings | 24.00M |
| Noxopharm | 22.43M |
| Algorae Pharmaceuticals | 21.24M |
| NeuroScientific Biopharmaceuticals | 20.62M |
| Neurotech International | 19.77M |
| Opthea | 19.15M |
| Proteomics International Laboratories | 19.00M |
| Cambium Bio | 12.98M |